Severity of RSV Infections in Twins (TwinSeVeRS)
Status
Conditions
Treatments
Details and patient eligibility
About
Respiratory syncytial virus (RSV) infection is the most common cause of severe lower respiratory tract infection (LRTI) in the pediatric population worldwide. Age at the time of infection, prematurity, multiparity, exposure to smoke and the level of passive immunity transmitted at birth are the main risk factors for lower respiratory infection associated with RSV. Other factors, including the innate immune response, respiratory microbiota, and intra-host viral heterogeneity, may also affect outcomes but are not fully considered in RSV infection. Exploring the impact of these factors is difficult due to the heterogeneity of the population which makes statistical adjustment difficult. Thus, twin models are useful in understanding the impact of the host on the environment, as twins often share similar exposure to infection and many risk factors, but not all are ie different prenatal and postnatal conditions, differential transfer of maternal antibodies and the genetic makeup of heterozygotes.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Twins born at Hospices Civils de Lyon in the years 2012 to 2020
- At least one twin hospitalized with positive RSV-PCR during the first year of life
Exclusion criteria
- Major differential underlying disease between twins
- Death of a twin before the RSV epidemic period of the first year of life
- Nosocomial infection
- Lack of understanding of the study or questionnaire by parents
- Lack of parental consent
Trial design
94 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal